Posts by David Masters-Moore, MBA, MS
Dave has over 20 years of experience in the field. He has held analytical chemistry roles specialized in HPLC, GC, SFC, and UPLC-MS/MS at Pharmchem Labs, Rohm and Haas, Pharmacia, Pfizer, Scripps Research Institute, Millennium Health, and Agilent. He now has oversight of the day-to-day operations within Analytical Chemistry, which includes the Dose Formulation Analysis team for validations and analytical studies, as well as the growth and expansion of the department's business operations.
Blogs
Preclinical formulation analysis supports toxicity studies before and after the investigational new drug application (IND). Multiple analytical studies support drug development progression beyond the IND stage. KCAS Bio performs analytical studies for a variety of clients. How Does KCAS Bio Perform Preclinical Formulation Analysis? KCAS Bio has completed numerous studies…
Blogs
In its simplest terms, Dose Formulation Analysis (DFA) verifies all solutions used in preclinical toxicology studies. For FDA IND applications, dose formulation analysis is critical. Some companies are unfamiliar with the DFA process or…
Blogs
Dose Formulation Analysis is an essential step in regulated nonclinical studies. Robust analytical methods, rapid turnaround, and efficient communication helps ensure the dose form results for your GLP studies are delivered on time. At…